Evaluation of hepcidin-25/erythroferrone ratio as a potential biomarker for iron utility and erythropoiesis responsiveness to erythropoiesis-stimulating therapy in comparison to immature erythrocyte/reticulocyte parameters in hemodialysis patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Evaluation of hepcidin-25/erythroferrone ratio as a potential biomarker for iron utility and erythropoiesis responsiveness to erythropoiesis-stimulating therapy in comparison to immature erythrocyte/reticulocyte parameters in hemodialysis patients

Published:2024-08 Issue: Volume: Page:
ISSN:2531-1379
Container-title:Hematology, Transfusion and Cell Therapy
language:en
Short-container-title:Hematology, Transfusion and Cell Therapy

Author:

Bakr Salwa^ORCID,Salem Karem Mohamed,Rashed Ahmed Mohammed,Tantawy Mohamed E A,Elsary Asmaa Younis,Shamardl Hanan Abdelmoneam^ORCID,Ezzat Eman Mahmoud

Publisher

Elsevier BV

Reference30 articles.

1. Erythropoietin resistance in patients with chronic kidney disease: current perspectives;Santos;Int J Nephrol Renovasc Dis,2020

2. WHO EML 2016-2017. (2016). Application for erythropoietin-stimulating agents (erythropoietin type blood factors) Version 3, 23 December 2016.

3. Erythropoiesis-stimulating agents for anaemia in adults with chronic kidney disease: a network meta-analysis;Palmer;Cochrane Database Systematic Rev,2014

4. Biomarkers of iron metabolism in chronic kidney disease;Tomasz;Int Urol Nephrol,2021

5. Associations among erythroferrone and biomarkers of erythropoiesis and iron metabolism, and treatment with long-term erythropoiesis-stimulating agents in patients on hemodialysis;Honda;PLoS One,2016

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP